126 studies found for:    Enzalutamide
Show Display Options
Rank Status Study
1 Completed Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Conditions: Prostate Cancer;   Pharmacokinetics of Enzalutamide
Interventions: Drug: Enzalutamide tablet;   Drug: Enzalutamide capsule
2 Active, not recruiting Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Condition: Breast Cancer
Interventions: Drug: enzalutamide;   Drug: anastrozole;   Drug: exemestane;   Drug: fulvestrant
3 Completed A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
Conditions: Drug-Drug Interaction (DDI);   Healthy Subjects;   Pharmacokinetics of Enzalutamide
Interventions: Drug: enzalutamide;   Drug: rifampin
4 Completed A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
Conditions: Severe Hepatic Impairment;   Normal Hepatic Function
Intervention: Drug: enzalutamide
5 Completed A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
Conditions: Healthy Subjects;   Castration Resistant Prostate Cancer (CRPC);   Relative Bioavailability;   MDV3100
Intervention: Drug: MDV3100
6 Active, not recruiting Enzalutamide in Patients With High-risk Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: enzalutamide
7 Active, not recruiting Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: exemestane;   Drug: Placebo (for enzalutamide)
8 Recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Not yet recruiting Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone
Condition: Cancer
Interventions: Drug: Afuresertib;   Drug: Enzalutamide;   Drug: Abiraterone;   Drug: Prednisone
10 Not yet recruiting Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Condition: Metastatic Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Niraparib
11 Completed Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Conditions: Castration Resistant Prostate Cancer (CRPC);   Pharmacokinetics of MDV3100
Interventions: Drug: MDV3100;   Drug: Pioglitazone;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam
12 Active, not recruiting Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone;   Drug: Placebo for Enzalutamide;   Drug: Prednisone
13 Recruiting Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Everolimus;   Drug: Enzalutamide
14 Recruiting A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Drug: enzalutamide;   Drug: placebo
15 Recruiting RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)
Condition: Prostate Cancer
Interventions: Drug: Testosterone cypionate;   Drug: Testosterone Enanthate;   Drug: Abiraterone acetate;   Drug: Enzalutamide
16 Active, not recruiting Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Bicalutamide
17 Recruiting Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
Condition: Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: Androgen Deprivation;   Radiation: Radiation Therapy
18 Recruiting An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Patients
Condition: Progressive Metastatic Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: Placebo
19 Recruiting Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
Condition: Castration Resistant Metastatic Prostate Cancer
Interventions: Drug: Testosterone cypionate;   Drug: Enzalutamide;   Drug: Testosterone Enanthate
20 Recruiting Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Conditions: Hormone Sensitive Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo;   Drug: Leuprolide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years